Analytical Method Lifecyle of SFC Methods from Development Use to Routine QC Implementation: Supporting Small Molecule R&D and Commercialization
LCGC International · 2024
DOI: 10.56530/lcgc.int.bc1965m2 ↗Kurz gefasst
Fachartikel in der Zeitschrift LCGC International, 2024. Verfasst von Claudia Brunelli und 1 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Selection of the correct analytical technique from the outset of method development is key in securing the optimal and most robust method to be used throughout a product’s development journey from R&D to commercialization. In this article, we review some key considerations for chromatographic technique selection and method development across the full drug process—from early-stage active pharmaceutical ingredient (API) synthesis to routine commercial release activities. We describe the implementation of supercritical fluid chromatography (SFC) in the pharmaceutical industry, especially for chiral, water sensitive analytes, and low to high LogP and LogD hydrophobic compounds, while demonstrating high levels of method robustness and support of “green” analytics.
Zitieren
APA
Brunelli, C., & Callar, W. (2024). Analytical Method Lifecyle of SFC Methods from Development Use to Routine QC Implementation: Supporting Small Molecule R&D and Commercialization. LCGC International. https://doi.org/10.56530/lcgc.int.bc1965m2
Vancouver
Brunelli C, Callar W. Analytical Method Lifecyle of SFC Methods from Development Use to Routine QC Implementation: Supporting Small Molecule R&D and Commercialization. LCGC International. 2024. doi:10.56530/lcgc.int.bc1965m2
BibTeX
@article{Brunelli2024,
author = {Brunelli, Claudia and Callar, Wayne},
title = {Analytical Method Lifecyle of SFC Methods from Development Use to Routine QC Implementation: Supporting Small Molecule R&D and Commercialization},
journal = {LCGC International},
year = {2024},
doi = {10.56530/lcgc.int.bc1965m2}
}
EUVIMED